Takeda makes US R&D appointment
This article was originally published in Scrip
Executive Summary
Dr Azmi Nabulsi has been appointed president of the Takeda Global Research & Development Center in the US. He succeeds Dr Nancy Joseph-Ridge, who has been named general manager of the Japanese firm's US pharmaceutical development division. This operates under Takeda Pharmaceuticals International, a new wholly owned US entity formed in a recent restructuring of corporate R&D activities (scripnews.com, March 31st, 2009). Dr Nabulsi joined Takeda in 2004 and was most recently general manager of the strategic development department at its Osaka headquarters.